A primary biliary cholangitis (PBC) diagnosis can be life-changing. For many, it’s an emotional journey filled with questions, uncertainties and a need to redefine what life looks like with a ...

Polaris Global Equity Strategy highlighted stocks like Gilead Sciences ... drug trial reduced new infections by 96% when compared to background HIV incidence, which could be a game changer ...

Promise. MAC's Ruby Woo has been around since 1999 and is arguably *the* most iconic red lipstick of all time. With cool blue undertones that make your teeth look dazzling white and a rich pigment ...

Gilead's stock has surged due to successful launches of Livdelzi for PBC and promising developments in lenacapavir for HIV prevention. Livdelzi's approval and strong market potential, combined ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...

-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- -- Gilead Has Exclusive Option to Develop and ...

It’s a December to remember for Prime Video. Per the streamer, the Dwayne Johnson and Chris Evans Christmas flick “Red One” attracted a record-breaking 50 million worldwide viewers in its ...

The Food and Drug Administration has not formally reevaluated the safety of a food dye called Red 40 in over a decade, the agency's top food official said this month when asked about renewed ...

Details are thin on the ground, but we know Gilead is tapping into Terray’s so-called tNova platform, the startup’s generative AI. This platform is designed to improve the speed, cost and ...

-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- FOSTER CITY, Calif. & LOS ANGELES--(BUSINESS WIRE ...